Journal Tagged "cannabinoid research" Page 2

.product_section .product_form, .product_gallery { opacity: 1; } .multi_select, form .select { display: block !important; } .image-element__wrap { display: none; }

Cannabinoids in possible treatment of MS

3 min read

Much research has been done on whether and how cannabinoids might be able to function in control of multiple sclerosis symptoms. There is room for optimism.

cannabinoid research multiple sclerosis

Cannabinoids in possible treatment of HIV dementia

2 min read

Synthetic cannabinoids as potential therapeutic agents in HIV-related neuropathogenesis in the brain is beginning to emerge as a possibility.

cannabinoid research

Cannabinoids in treatment of vascular dementia

2 min read

Presently, for vascular dementia, there is no satisfactory drug treatment. Cannabinoids may in time prove of value in therapeutic intervention.

cannabinoid research vascular dementia

Cannabinoids in common dementia: a research overview

2 min read

Practical trials of cannabinoids in dementia so far are turning up data that warrant more investigation for possible therapeutic intervention. Cannabidiol (CBD), an inverse agonist for several neural receptor sites, is of particular interest at the moment.

cannabidiol cannabinoid research CBD dementia pharmaceutical cannabinoids

Previous 1 2

“With DiolPure, I can finally recommend CBD because I can trust the source, quality and purity rather than hoping that what I’m recommending won’t have fillers or neurotoxins, mycotoxins, and THC.”

- Mary, Los Angeles